Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Slashes Sales Force 20%

This article was originally published in The Pink Sheet Daily

Executive Summary

Company announces first of its cost-cutting initiatives, which could produce ripple effects across the industry.

You may also be interested in...



Pfizer Looks To Make Its Big Pharma Engine More Agile By Cutting 10,000

Company's reorganization will include R&D rationalization, manufacturing consolidation and European field force cuts.

Pfizer Looks To Make Its Big Pharma Engine More Agile By Cutting 10,000

Company's reorganization will include R&D rationalization, manufacturing consolidation and European field force cuts.

Pfizer Plans Four New Products A Year Starting In 2011

Company highlights strength of pipeline at R&D briefing, but says it will rely on a near-term licensing strategy to address “gaps.”

Topics

UsernamePublicRestriction

Register

ID1132542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel